We are live on !
Find out more
Tonix Pharmaceuticals
TNXP
TNXP
hedge funds and large institutions have $1.3M invested in Tonix Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
17.56% less ownership
Funds ownership: 21.27% → 3.71% (-18%)
100% less capital inflows, than outflows
Capital inflows: $0 | Capital outflows: $626K
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $5K
Holders
Holders Change
–
Holders Change %
–
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
$5K
Net Calls
-$5K
Net Calls Change
+$111K
Top Buyers
No buyers this quarter
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$151K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$142K |
| 3 |
D.E. Shaw & Co
New York
|
-$82K |
| 4 |
Millennium Management
New York
|
-$76K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$72K |